Medicine shortages in Fiji: A qualitative exploration of stakeholders’ views
Open accessAbstract
OBJECTIVES: Medicine access is a human right; yet, concerningly, there are international instances of shortages. Quantitative data has allowed WHO to propose global solutions; however, individualised understanding of specific regions is still required to work towards national solutions. Fiji has an established issue with medication supply and the aim of this study was to use qualitative methods to gain a fuller understanding of this context. METHODS: Semi-structured interviews were used to gain the perspective of key stakeholders involved in the Fijian medicine supply chain in regards to causes, impacts and possible solutions of medicine shortages. Thematic analysis was used to analyse the interview data. RESULTS: In total, 48 stakeholders participated and the information was synthesised into three main themes, causes, impacts and solutions and the sub-themes including; political, system and patient causes, adverse health effects on patients, professional dissatisfaction, monetary loss and loss of faith in the health system, workarounds, operation improvements, government intervention and education and training. CONCLUSIONS: The situation in Fiji is not dissimilar to other instances of shortages around the world and hence international solutions like that proposed by WHO are feasible; however, they must be modified to be uniquely Fijian to work in this context.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Medicine shortages are a complex global challenge affecting all countries, including South Africa, with shortages of even essential medicines becoming a global problem irrespective of the economic status of countries.
“Over the years, the shortage of medicines has been a challenge to the effective delivery of quality healthcare services worldwide including South Africa [1–10], with shortages of even essential medicines becoming a global problem irrespective of the economic status of countries [11–13].”
From Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications (2020) · cites this paper as [9]
The Introduction describes medicine shortages as a global phenomenon that risks interrupting treatment, and the Results > Causes documents shortages affecting essential medicines in Fiji. The paper does not establish that shortages affect all countries regardless of economic status; South Africa appears in its references, but the paper does not discuss its situation in the text provided. (LLM, conf=0.78)
Experimental — accuracy not yet measuredMultiple factors contribute to medicine shortages, including manufacturing and quality problems, production delays, lack of manufacturing capacity, shortage of raw materials, political instability, profitability issues, long lead times, delays in awarding tenders, absence of national contracts on regional code lists, failure of suppliers to meet demand, and failure to pay suppliers.
“Some of the contributing factors to the shortage of medicines include manufacturing and quality problems, production delays, lack of manufacturing capacity, shortage of raw materials, political instability, and profitability issues [5, 6, 8, 9, 18].”
From Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications (2020) · cites this paper as [9]
The Introduction (page unavailable) names manufacturing problems and financial issues as causes of medicine shortages. Results > Causes (page unavailable) describes tender and transport delays, suppliers unable to meet set prices, and lack of profit discouraging private buyers from stocking medicines. The paper does not establish the citing sentence’s more specific claims about quality problems, production delays, manufacturing capacity, raw-material shortages, or political instability. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Kirk, J. M. W., MacDonald, A., Lavender, P., Dean, J. M., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,901 · see citing works
Shared decision making — The pinnacle of patient-centered care
Barry, M. J., & Edgman-Levitan, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1109283 · Cited by 3,433 · see citing works
Medication Adherence: WHO Cares?
Brown, M. T., & Bussell, J. K. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0575 · Cited by 1,928 · see citing works
Mills, E. J., Nachega, J. B., Bangsberg, D. R., Singh, S., Rachlis, B., Wu, P., Wilson, K., Buchan, I., Gill, C. J., & Cooper, C. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030438 · Cited by 818 · see citing works
Xie, J., Wertz, F. J., Charmaz, K. C., McMullen, L. M., Josselson, R., Anderson, R., & McSpadden, E. L. (2013) · QMiP Bulletin · doi:10.53841/bpsqmip.2013.1.15.56 · Cited by 806 · see citing works
Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices
Prasad, V., & Ioannidis, J. P. (2014) · Implementation Science · doi:10.1186/1748-5908-9-1 · Cited by 723 · see citing works
Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease
Kesselheim, A. S. (2008) · JAMA · doi:10.1001/jama.2008.758 · Cited by 436 · see citing works
Gustafsson, L. L., Wettermark, B., Godman, B., Karlsson, E., Bergman, U., Hasselström, J., Hensjö, L., Hjemdahl, P., Jägre, I., Julander, M., et al. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00682.x · Cited by 227 · see citing works
Dunne, S. S., & Dunne, C. P. (2015) · BMC Medicine · doi:10.1186/s12916-015-0415-3 · Cited by 191 · see citing works
Seizure Outcomes Following the Use of Generic versus Brand-Name Antiepileptic Drugs
Kesselheim, A. S., Stedman, M. R., Bubrick, E. J., Gagne, J. J., Misono, A. S., Lee, J. L.-Y., Brookhart, M. A., Avorn, J., & Shrank, W. H. (2010) · Drugs · doi:10.2165/10898530-000000000-00000 · Cited by 190 · see citing works
Database searches for qualitative research.
Evans, D. J. (2002) · Europe PMC (PubMed Central) · Cited by 179 · see citing works
Hassali, M. A., Alrasheedy, A. A., McLachlan, A. J., Nguyen, T. A., AL‐Tamimi, S. K., Ibrahim, M. I. M., & Aljadhey, H. S. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.12.017 · Cited by 159 · see citing works
Comparative Effectiveness of Generic and Brand-Name Statins on Patient Outcomes: A Cohort Study
Gagne, J. J., Choudhry, N. K., Kesselheim, A. S., Polinski, J. M., Hutchins, D., Matlin, O. S., Brennan, T. A., Avorn, J., & Shrank, W. H. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2942 · Cited by 155 · see citing works
Essential medicines and human rights: what can they learn from each other?
Hogerzeil, H. V. (2006) · Bulletin of the World Health Organization · doi:10.2471/blt.06.031153 · Cited by 153 · see citing works
Pasquet, A., Messou, E., Gabillard, D., Minga, A. K., Depoulosky, A., Deuffic‐Burban, S., Losina, E., Freedberg, K. A., Danel, C., Anglaret, X., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013414 · Cited by 132 · see citing works
Essential medicines are more available than other medicines around the globe
Bazargani, Y. T., Ewen, M., de Boer, A., Leufkens, H. G. M., & Mantel-Teeuwisse, A. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087576 · Cited by 126 · see citing works
Insights into European Drug Shortages: A Survey of Hospital Pharmacists
Pauwels, K., Simoens, S., Casteels, M., & Huys, I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119322 · Cited by 121 · see citing works
Scheidel, W. (2009) · Wiley eBooks · doi:10.1002/9781444308372.ch13 · Cited by 113 · see citing works
DeRoeck, D., Bawazir, S. A., Carrasco, P., Kaddar, M., Brooks, A., Fitzsimmons, J. W., & Andrus, J. K. (2006) · The International Journal of Health Planning and Management · doi:10.1002/hpm.822 · Cited by 106 · see citing works
Access to cancer medications in low- and middle-income countries
Lopes, G. D. L., Jr., de Souza, J. A., & Barrios, C. H. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.55 · Cited by 99 · see citing works
Fry, G., & Tarte, S. (2015) · ANU Press eBooks · doi:10.22459/npd.12.2015 · Cited by 91 · see citing works
Tourism, Land Tenure and Poverty Alleviation in Fiji
Scheyvens, R. A., & Russell, M. (2011) · Tourism Geographies · doi:10.1080/14616688.2011.593188 · Cited by 87 · see citing works
Godman, B., Bishop, I., Finlayson, A. E. T., Campbell, S., Kwon, H.-Y., & Bennie, M. (2013) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2013.820956 · Cited by 86 · see citing works
Kessaram, T., McKenzie, J., Girin, N., Roth, A., Vivili, P., Williams, G. M., & Hoy, D. G. (2015) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.12398 · Cited by 84 · see citing works
Bogaert, P., Bochenek, T., Prokop, A., & Pilc, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125691 · Cited by 80 · see citing works
Bossert, T. J., Bowser, D. M., & Amenyah, J. K. (2007) · Health Policy and Planning · doi:10.1093/heapol/czl041 · Cited by 79 · see citing works
Garuolienè, K., Godman, B., Gulbinovič, J., Wettermark, B., & Haycox, A. R. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.24 · Cited by 77 · see citing works
Gijbels, H., O’Connell, R., Dalton, C., & O’Donovan, M. (2009) · Nurse Education in Practice · doi:10.1016/j.nepr.2009.03.011 · Cited by 71 · see citing works
Drug stock-outs: Inept supply-chain management and corruption
Bateman, C. (2013) · South African Medical Journal · doi:10.7196/samj.7332 · Cited by 65 · see citing works
The Impact of Anti-infective Drug Shortages on Hospitals in the United States: Trends and Causes
Griffith, M., Gross, A. E., Sutton, S. H., Bolon, M. K., Esterly, J. S., Patel, J. A., Postelnick, M. J., Zembower, T., & Scheetz, M. H. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir954 · Cited by 63 · see citing works
Dowswell, T., Hewison, J., & Hinds, M. (1998) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.1998.00841.x · Cited by 59 · see citing works
Decentralisation of Health Services in Fiji: A Decision Space Analysis
Mohammed, J., North, N., & Ashton, T. (2015) · International Journal of Health Policy and Management · doi:10.15171/ijhpm.2015.199 · Cited by 53 · see citing works
Medicine shortages in Australia: causes, impact and management strategies in the community setting
Tan, Y. X., Moles, R. J., & Chaar, B. B. (2016) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-016-0342-1 · Cited by 48 · see citing works
Self-citationBanek, K., Nankabirwa, J. I., Maiteki‐Sebuguzi, C., DiLiberto, D., Taaka, L., Chandler, C., & Staedke, S. G. (2014) · Health Policy and Planning · doi:10.1093/heapol/czu033 · Cited by 47 · see citing works
Are generic and brand-name statins clinically equivalent? Evidence from a real data-base
Corrao, G., Soranna, D., Arfè, A., Casula, M., Tragni, E., Merlino, L. G., Mancia, G., & Catapano, A. L. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.08.002 · Cited by 45 · see citing works
Drug Shortages: Patients and Health Care Providers Are All Drawing the Short Straw
Rinaldi, F., de Denus, S., Nguyen, A., Nattel, S., & Bussières, J. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.08.010 · Cited by 43 · see citing works
Generic clozapine: outcomes after switching formulations
Paton, C. (2006) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.105.017079 · Cited by 41 · see citing works
Corrao, G., Soranna, D., Merlino, L. G., & Mancia, G. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12326 · Cited by 38 · see citing works
Fry, G., & Tarte, S. (2016) · ANU Press eBooks · doi:10.26530/oapen_603144 · Cited by 31 · see citing works
Generic olanzapine: health authority opportunity or nightmare?
Araszkiewicz, A. S., Szabert, K., Godman, B., Władysiuk, M., Barbui, C., & Haycox, A. R. (2008) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.8.6.549 · Cited by 28 · see citing works
Mitigating regulatory impact: the case of partial price controls on metformin in India
Bhaskarabhatla, A., Chatterjee, C., Anurag, P., & Pennings, E. (2016) · Health Policy and Planning · doi:10.1093/heapol/czw109 · Cited by 24 · see citing works
Essential Medicines in a High Income Country: Essential to Whom?
Duong, M. H., Moles, R. J., Chaar, B. B., & Chen, T. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143654 · Cited by 20 · see citing works
Self-citationLubinga, S. J., Jenny, A. M., Larsen-Cooper, E., Crawford, J., Matemba, C., Stergachis, A. S., & Babigumira, J. B. (2014) · Implementation Science · doi:10.1186/s13012-014-0156-2 · Cited by 19 · see citing works
Should we have concerns with generic versus brand antimicrobial drugs? A review of issues
Veronin, M. A. (2011) · Journal of Pharmaceutical Health Services Research · doi:10.1111/j.1759-8893.2011.00059.x · Cited by 18 · see citing works
Making on-line logistics training sustainable through e-learning
Wu, Y. J., & Huang, S. K. (2012) · Computers in Human Behavior · doi:10.1016/j.chb.2012.07.027 · Cited by 16 · see citing works
Qureshi, N. A., Kundi, G. M., Qureshi, Q. A., Akhtar, R., & Hussain, L. (2015) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · Cited by 14 · see citing works
A Study of the Management of Electronic Medical Records in Fijian HospitalsPreprint
Ravindra, S. S., Chandra, R., & Dhenesh, V. S. (2015) · arXiv (Cornell University) · doi:10.48550/arxiv.1507.03659 · Cited by 12 · see citing works
Medicine shortages: Implications for the Australian healthcare system
Chaar, B. B. (2014) · Australasian Medical Journal · doi:10.4066/amj.2014.1943 · Cited by 5 · see citing works
Self-citationColquhoun, S., Read, C., Ward, B., Taito, R., Matatolu, L., Matanatabu, F., Kee, M. A., Vincente, S. F. L., Kado, J. H., & Steer, A. C. (2016) · Global Heart · doi:10.1016/j.gheart.2016.03.214 · Cited by 2 · see citing works
Möller, S. P. (2013) · Pharmacy management · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- [3]Anonymous. Medicine shortages—Finding local solutions to a global problem. SA Pharmaceutical Journal. 2013; 80(10): 45– 7.
- [6]Hedman L. Global approaches to addressing shortages of essential medicines in health systems. WHO Drug Information. 2016; 30(2): 180.
- [14]Dr Graham Roberts FNU, Dr Wayne Irava FNU, Dr Timaima Tuiketei FNU, Ms Rigieta Nadakuitavuki IC, Mr Sisa Otealagi MoH, Fiji, Dr Sheetal Singh MoH, Fiji, et al. The Fiji Islands Health System Review. Health Systems in Transition Asia Pacific Observatory on Health Systems and Policies; 2011. p. 19–39.
Cited by
Sorted by citations
Drug Shortage: Causes, Impact, and Mitigation Strategies
Shukar, S., Zahoor, F., Hayat, K., Saeed, A., Gillani, A. H., Omer, S., Hu, S., Babar, Z., Fang, Y., & Yang, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.693426 · Cited by 348 · see citing works
The impacts of medication shortages on patient outcomes: A scoping review
Phuong, J., Penm, J. H.-D., Chaar, B. B., Oldfield, L., & Moles, R. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215837 · Cited by 261 · see citing works
Self-citationGlobal drug shortages due to COVID-19: Impact on patient care and mitigation strategies
Badreldin, H. A., & Atallah, B. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.05.017 · Cited by 176 · see citing works
Medicine Shortages: Gaps Between Countries and Global Perspectives
Acosta, A., Vanegas, E. P., Rovira, J., Godman, B., & Bochenek, T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00763 · Cited by 147 · see citing works
Modisakeng, C., Matlala, M., Godman, B., & Meyer, J. C. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-05080-1 · Cited by 130 · see citing works
“There are also considerable shortages in other continents and countries including other low and middle income countries (LMICs) across South America and wider [5, 6, 8, 9].”
BackgroundBochenek, T., Abilova, V., Alkan, A., Asanin, B., de Miguel Beriain, I., Besovic, Z., Vella Bonanno, P., Bucsics, A., Davidescu, M., De Weerdt, E., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00942 · Cited by 112 · see citing works
“…et al., 2013; Costelloe et al., 2014; Goldsack et al., 2014; Bogaert et al., 2015; Butterfield et al., 2015; De Weerdt et al., 2015b, 2017b; Pauwels et al., 2015; Alsheikh et al., 2016; Awad et al., 2016; Yang et al., 2016; Heiskanen et al., 2017; Mazer-Amirshahi et al., 2017; Walker et al., 2017).”
Atif, M., Malik, I., Mushtaq, I., & Asghar, S. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027028 · Cited by 68 · see citing works
Atif, M., Sehar, A., Malik, I., Mushtaq, I., Ahmad, N., & Babar, Z. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06812-7 · Cited by 55 · see citing works
Stakeholder theory and management: Understanding longitudinal collaboration networks
Fares, J., Chung, K. S. K., & Abbasi, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255658 · Cited by 55 · see citing works
Atif, M., Malik, I., Asif, M., Qamar-uz-Zaman, M., Ahmad, N., & Scahill, S. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819837-7.00024-8 · Cited by 29 · see citing works
Muthathi, I. S., Levin, J., & Rispel, L. C. (2019) · Health Policy and Planning · doi:10.1093/heapol/czz166 · Cited by 27 · see citing works
Bilal, A. I., Bititci, U., & Fenta, T. G. (2024) · Pharmacy · doi:10.3390/pharmacy12050132 · Cited by 24 · see citing works
AlAzmi, A., Jastaniah, W. A., Alhamdan, H. S., Alyamani, A., AlKhudhyr, W. I., Abdullah, S., AlZahrani, M., Alsahafi, A., AlOhali, T. A., Alkhelawi, T., et al. (2020) · JCO Global Oncology · doi:10.1200/jgo.19.00230 · Cited by 18 · see citing works
AlAzmi, A., & AlRashidi, F. (2019) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s198375 · Cited by 17 · see citing works
The critical pharmaceutical situation in Sudan 2023: A humanitarian catastrophe of civil war
Hemmeda, L., Tiwari, A., Kolawole, B. O., Ayoobkhan, F. S., Fatima, K., Shabani, M. M., Kundu, M., Anugu, N. R., Richard, R. M., Ibrahim, D., et al. (2024) · International Journal for Equity in Health · doi:10.1186/s12939-024-02103-9 · Cited by 16 · see citing works
The Everyday Politics of Risk: Managing Diabetes in Fiji
Phillips, T. (2020) · Medical Anthropology · doi:10.1080/01459740.2020.1717489 · Cited by 16 · see citing works
Ipagala, P., Mlugu, E. M., Mwakalukwa, R., & Kagashe, G. A. B. (2023) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-023-00617-1 · Cited by 14 · see citing works
Alshibli, F., Alqarni, K. A., & Balfaqih, H. (2024) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2024.101457 · Cited by 14 · see citing works
Shukar, S., Zahoor, F., Omer, S., Ejaz, S., Yang, C., & Fang, Y. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192316373 · Cited by 13 · see citing works
Dong, J., Gao, Y., Liu, Y., & Yang, X. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284528 · Cited by 13 · see citing works
How coping can hide larger systems problems: the routine immunisation supply chain in Bihar, India
Lee, B. Y., Wedlock, P. T., Mitgang, E. A., Cox, S. N., Haidari, L. A., Das, M. K., Dutta, S., Kapuria, B., & Brown, S. T. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2019-001609 · Cited by 13 · see citing works
Romakin, P., & Mohammadnezhad, M. (2019) · Australian Journal of General Practice · doi:10.31128/ajgp-02-19-4859 · Cited by 10 · see citing works
Omer, S., Ali, S., Shukar, S., Gillani, A. H., Fang, Y., & Yang, C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182010665 · Cited by 9 · see citing works
Community Pharmacy Staff Knowledge, Opinion and Practice toward Drug Shortages in Saudi Arabia
Alsheikh, M. Y., Alzahrani, M. A., Alsharif, N. A., Altowairqi, H. M., Asiri, S. A., Althubaiti, B. M., Alshahrani, A., Fathelrahman, A. I., Alasmari, M. M., & Alotaibi, A. M. F. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.09.001 · Cited by 9 · see citing works
Medicines Shortages Reporting Systems (MSRS): An exploratory review of access and sustainability
Yaroson, E. V., Quinn, G., & Breen, L. (2024) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2024.02.010 · Cited by 6 · see citing works
Moral reasoning perspectives of community pharmacists in situations of drug shortages
Kruijtbosch, M., Floor‐Schreudering, A., van Leeuwen, E., Göttgens, W., & Bouvy, M. L. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.11.012 · Cited by 6 · see citing works
Satibi, S., Faradiba, F., Aditama, H., & Prasetyo, S. D. (2022) · INDONESIAN JOURNAL OF PHARMACY · doi:10.22146/ijp.2519 · Cited by 6 · see citing works
Atănăsoie, A.-M., Ancuceanu, R., Krajnović, D., Waszyk-Nowaczyk, M., Skotnicki, M., Tondowska, D., Petrova, G. I., Niculae, A. M., & Tăerel, A.-E. (2024) · Pharmaceuticals · doi:10.3390/ph17060793 · Cited by 5 · see citing works
Gohar, N., Ejaz, Z., Ahmed, F., Ahmed, A. R., Humayun, M. A., Nisar, M., Mushtaq, M. A., Ghouri, A., Zafar, F., Khalid, H., et al. (2025) · JGH Open · doi:10.1002/jgh3.70143 · Cited by 5 · see citing works
The Impact of COVID-19 on Children and Adolescents with Chronic Illness
Nearchou, F., & Flinn, C. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-61939-7_22 · Cited by 4 · see citing works
Key stakeholders’ views on the causes of medicine stock-outs in Mauritania: A qualitative study
Ahmed, M. A. A., Coulibaly, I. M., Ravinetto, R., Buitrago, V. T., & Dujardin, C. (2025) · PLoS ONE · doi:10.1371/journal.pone.0304930 · Cited by 4 · see citing works
Strengthening cancer control in the South Pacific through coalition-building: a co-design framework
Hyatt, A., Chan, B., Moodie, R., Varlow, M., Bates, C., Foliaki, S., Palafox, N. A., Burich, S., & Aranda, S. K. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2022.100681 · Cited by 4 · see citing works
Ledlie, S., Tadrous, M., McCormack, D., Campbell, T. J., Leece, P., Kleinman, R. A., Kolla, G., Besharah, J., Smoke, A., Sproule, B. A., et al. (2023) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2023.104119 · Cited by 3 · see citing works
The supply and demand challenges of medicines at Princess Marina Hospital, Gaborone, Botswana
Modutlwa, N., Moyo, S., & Tshuma, N. (2023) · International Journal of Innovation in Management Economics and Social Sciences · doi:10.59615/ijimes.3.3.1 · Cited by 3 · see citing works
Yap, W. S., Cheong, W. L., & Yeap, L. (2026) · Journal of Pharmaceutical Policy and Practice · doi:10.1080/20523211.2026.2701922 · Cited by 2 · see citing works
Nizam, V. P. M., Yerram, S., Ajmal, C. S., Raghuvanshi, R. S., & Srivastava, S. (2025) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-025-10009-4 · Cited by 2 · see citing works
Pakistan fears a shortage of life-saving drugs in the wake of the ‘worst economic crisis’
Muzzamil, M., Fatima, F., Irfan, S., Tahira, N., & Malikzai, A. (2024) · International Journal of Surgery Global Health · doi:10.1097/gh9.0000000000000396 · Cited by 2 · see citing works
Shortage of perioperative supplies and drugs: Theory and practical implications
Rincón‐Valenzuela, D. A., & Gómez-Ardila, C. (2024) · Colombian Journal of Anesthesiology · doi:10.5554/22562087.e1100 · Cited by 2 · see citing works
Drug Shortages and Its Effects on Service Delivery among Key Informants (KIs) in Fiji
Raikabakaba, A., Mohammadnezhad, M., Tamani, L., & Gaundan, D. (2022) · Global Journal of Health Science · doi:10.5539/gjhs.v14n5p1 · Cited by 2 · see citing works
Drug Shortage Concepts among Stakeholders in Saudi Arabia
Almutairi, M. G., Almomen, S. M., Alhazzani, H., Almutairi, B., Alenzi, A., & Hafiz, R. A. (2023) · Saudi Journal of Health Systems Research · doi:10.1159/000529168 · Cited by 2 · see citing works
Modutlwa, N. (2024) · International Journal of Innovation in Management Economics and Social Sciences · doi:10.59615/ijimes.4.2.14 · Cited by 2 · see citing works
Deweerdt, T., Johnstone, K. R., Jones, N. A., Richards, R., & Dargusch, P. (2024) · Research Square · doi:10.21203/rs.3.rs-5659753/v1 · Cited by 2 · see citing works
Hallal, H., Hoteit, M., Hallit, S. R., & Hallal, M. (2025) · Journal of Pharmaceutical Policy and Practice · doi:10.1080/20523211.2025.2464786 · Cited by 1 · see citing works
Strategies for addressing the shortage of medicines to improve service delivery
Modutlwa, N. (2024) · International Journal of Innovation in Management Economics and Social Sciences · doi:10.59615/ijimes.4.3.19 · Cited by 1 · see citing works
Ambulatory Care Pharmacist Perception of Formulary Medication Shortage: Tertiary Center Experience
Jaser, S., Aamer, K. A., Anizi, A. A., Javed, N. B., & Al-Mohaithef, M. (2021) · Hospital Pharmacy · doi:10.1177/00185787211051645 · Cited by 1 · see citing works
Russian and UK Dementia Action Plans: a comparative analysis
Koberskaya, N. N., & Kobierskij, B. (2021) · International Journal of Human Rights in Healthcare · doi:10.1108/ijhrh-09-2021-0166 · Cited by 1 · see citing works
López, L., & Stefany, J. (2021)
Moral dilemmas of community pharmacists Reflection on professional values
Kruijtbosch, M. (2021) · doi:10.33540/1008
Recurrent Erythema Nodosum Leprosum in a Lepromatous Leprosy Patient in Fiji
Swamy, V., & Yi, J.-H. (2021) · Korean Leprosy Bulletin · doi:10.33161/klb.2021.54.1.41
Towards a Basis for Policy Framework for Stockouts and Shortages of Drugs
Calucin, A. C. (2023) · International Conference on Industrial Engineering and Operations Management (IEOM) · doi:10.46254/an12.20220352
Workplace stressors and their impact on the nurse managers role
Boitshwarelo, T. (2024) · International Journal of Health Sciences · doi:10.53730/ijhs.v8n3.15248
Tackling Drug Shortages: An In-Depth Systematic Review Protocol
Alshammari, M. K., Alraya, R. A., Aljabri, A. K., Alsaadi, B., Althubyani, M. M., Alamri, S., Alqarni, A., Alenazi, Y. M., Almutairi, A., Alshehri, A., et al. (2025) · Pharmacy Practice · doi:10.18549/pharmpract.2025.2.3176
Atif, M., Sehar, A., Malik, I., Mushtaq, I., Ahmad, N., & Babar, Z.-U.-D. (2021) · Figshare · doi:10.6084/m9.figshare.15184538
Atif, M., Sehar, A., Malik, I., Mushtaq, I., Ahmad, N., & Babar, Z.-U.-D. (2021) · Figshare · doi:10.6084/m9.figshare.15184541
Stakeholder Perspectives on the Structural Causes of Drug Shortages in Korea: A Mixed-Methods Study
Kim, C., Park, E., & Kim, D. (2026) · International Journal of Health Policy and Management · doi:10.34172/ijhpm.9451
Singh, I. V., Phillips, G. A., & Khan, S. (2026) · Emergency Medicine Australasia · doi:10.1111/1742-6723.70333
- Authors
- Walker, J., Chaar, B. B., Vera, N., Pillai, A. S., Lim, J. S., Bero, L., & Moles, R. J.
- Affiliations
- The University of Sydney (AU)
- Fiji National University (FJ)
- Corresponding author
- Walker, Josephine
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-06-05
- Volume
- 12
- Issue
- 6
- Pages
- e0178429
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5459560
- OpenAlex
- W2624094502
- Cited by
- 57
- References
- 51
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 12 · 2023: 7 · 2022: 3 · 2021: 13 · 2020: 6 · 2019: 7 · 2018: 1
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- New Colombo Plan Mobility Program (2016NCPSEMFIJI16714)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Health Sciences › Health Professions › Emergency Medical Services › Global Health Workforce Issues
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
- Keywords
- drug shortages, pharmaceutical supply chain, Fiji, stakeholder perspectives, state intervention, access to medicines
- MeSH terms
- Fiji, Humans, Health Knowledge, Attitudes, Practice, Pharmacists, Physicians, Politics, Surveys and Questionnaires, Patient Satisfaction, Drugs, Essential, Qualitative Research, Prescription Drugs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
